Proper Name: Hepatitis B Vaccine (Recombinant), Adjuvanted
Manufacturer: Dynavax Technologies Corporation
- Indicated for prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.
- Package Insert - HEPLISAV-B
- Demographic Subgroup Information - Hepatitis B Vaccine (Recombinant), Adjuvanted; HEPLISAV-B
Refer to Section 1.1 of the clinical reviewer memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.